Results 201 to 210 of about 321,930 (219)

Open access in silico tools to predict the ADMET profiling of drug candidates

Expert Opinion on Drug Discovery, 2020
Jerzy Leszczynski, Supratik Kar
exaly  

In silico thrombectomy trials for acute ischemic stroke

Computer Methods and Programs in Biomedicine, 2023
Yvo Roos, Giulia Luraghi, Henk Marquering   +2 more
exaly  

In Silico Studies to Support Vaccine Development

Pharmaceutics, 2023
Ülo Langel, Nuno Vale, Leonor Pessanha Saldanha   +2 more
exaly  

In silico toxicology: From structure–activity relationships towards deep learning and adverse outcome pathways

Wiley Interdisciplinary Reviews: Computational Molecular Science, 2020
Jennifer Hemmerich, Gerhard Ecker
exaly  

A Guide to In Silico Drug Design

Pharmaceutics, 2023
Bryson Hawkins, David E. Hibbs, Paul W. Groundwater   +2 more
exaly  

In silico pharmacology for drug discovery: applications to targets and beyond

British Journal of Pharmacology, 2007
Jordi Mestres, Sean Ekins
exaly  

In Silico ADMET Traffic Lights as a Tool for the Prioritization of HTS Hits

ChemMedChem, 2006
Alexander Hillisch, Mario Lobell, Berthold Hinzen   +2 more
exaly  

G protein-coupled receptors: In silico drug discovery in 3D

Proceedings of the National Academy of Sciences of the United States of America, 2004
Yael Marantz
exaly  

Nanotoxicology data for in silico tools: a literature review

Nanotoxicology, 2020
Martin Mullins, Irini Furxhi, Craig A Poland   +2 more
exaly  

In silico ADME-Tox modeling: progress and prospects

Expert Opinion on Drug Metabolism and Toxicology, 2017
Saeed Alqahtani
exaly